✦ LIBER ✦

5133 Incidence of distant metastasis (DM) in elderly postmenopausal women with operable breast cancer treated with tamoxifen (TAM)

✍ Scribed by Doughty, J.; Mansell, J.; Monypenny, I.; Skene, A.; Abram, P.; Carpenter, R.; Gattuso, J.; Wilson, C.; Angerson, W.

Book ID: 123208298
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 66 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71025-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma levels of the atherogenic amino a

Plasma levels of the atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifen

✍ G. Anker; P. E. Lonning; P. M. Ueland; H. Refsum; E. A. Lien 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 488 KB 👁 2 views

Long-term treatment of breast-cancer patients with the anti-oestrogen tamoxifen has been found to be associated with reduced cardiovascular mortality. Plasma homocysteine is an independent risk factor for atherosclerotic disease, and its level is determined by folate and cobalamin status, and possib

Pharmacoeconomic analysis of adjuvant th

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

The effect of anastrozole (Arimidex™) on

The effect of anastrozole (Arimidex™) on serum lipids — a randomized comparison of Anastrozole (AN) vs Tamoxifen (TAM) in Postmenopausal women with Advanced Breast Cancer

✍ J. Dewar; J.M. Nabholtz; J. Bonneterre; A. Buzdar; J.F.R. Robertson; B. Thürlima 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Efficacy of pre-operative Arimidex (anas

Efficacy of pre-operative Arimidex (anastrozole) compared with tamoxifen (PROACT) as neoadjuvant therapy in postmenopausal women with hormone receptor-positive breast cancer

✍ L Cataliotti; A Buzdar; S Noguchi; J Bines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Prognostic factors in elderly women with

Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: An analysis of patients entered on four prospective clinical trials

✍ Madhav V. Dhodapkar; James N. Ingle; Stephen S. Cha; James A. Mailliard; H. Sam 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

## BACKGROUND. Information regarding prognostic factors and survival in elderly women with metastatic breast cancer treated with tamoxifen is limited. METHODS. The data from 4 prospective clinical trials were analyzed, including information on 396 postmenopausal women with advanced breast cancer w

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br